DUBLIN--(BUSINESS WIRE)--The "Cell Dissociation Market by Product (Enzymatic (Collagenase, Trypsin, DNase, Elastase) Non-enzymatic), Type (Tissue Dissociation), Tissue (Connective, Epithelial), End User (Pharmaceutical, Research Institutes) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
The cell dissociation market is expected to reach USD 440.5 million by 2023 from USD 241.2 million in 2018, at a CAGR of 12.8%.
Factors driving the growth of this market include rising government funding for chronic disease research and increasing R&D investment in pharmaceutical & biotechnology companies. On the other hand, emerging economies such as China, India, and Brazil are providing lucrative opportunities for the players operating in the cell dissociation market.
Based on product, the market is segmented into enzymatic dissociation products, non-enzymatic dissociation products, and instruments & accessories market. Among all, the non-enzymatic product segment is estimated to grow at the highest CAGR during the forecast period. This can be primarily attributed to advantages such as ready to use and non-toxic in nature.
On the basis of type, the market is segmented into tissue dissociation and cell detachment. The tissue dissociation segment dominated the market in 2017. Increasing demand for enzymatic products and instruments & accessories in the pharmaceutical & biotechnology companies is the major driving factor for this segment.
Geographically, the cell dissociation market was dominated by North America, followed by Europe in 2017. However, Asia Pacific is estimated to grow at the fastest rate due to infrastructural developments in the life sciences industry, rising government investments for chronic disease research, and presence of emerging economies such as China and India.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Cell Dissociation Market, By Product
7 Cell Dissociation Market, By Tissue
8 Cell Dissociation Market, By Type
9 Cell Dissociation Market, By End User
10 Cell Dissociation Market, By Region
11 Competitive Landscape
12 Company Profiles
- F. Hoffmann-La Roche Ltd.
- GE Healthcare
- Himedia Laboratories
- Merck KGaA
- Miltenyi Biotec
- Stemcell Technologies
- Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/research/9tw655/cell_dissociation?w=4